These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6462154)

  • 21. [Formation of treatment motivation in patients with pulmonary tuberculosis].
    Lebedeva NO; Sukhova EV
    Probl Tuberk Bolezn Legk; 2006; (12):13-6. PubMed ID: 17300066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relapse in patients with tuberculosis.
    Campbell AH
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():219-22. PubMed ID: 4468003
    [No Abstract]   [Full Text] [Related]  

  • 23. Intravenous use of rifampicin.
    Nilsson BS; Boman G
    Eur J Respir Dis; 1981 Jun; 62(3):212-4. PubMed ID: 7308336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perceptions and practices related with tuberculosis and treatment compliance in Chiapas, Mexico].
    Alvarez-Gordillo GC; Alvarez-Gordillo JF; Dorantes-Jiménez JE; Halperin-Frisch D
    Salud Publica Mex; 2000; 42(6):520-8. PubMed ID: 11201580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors affecting patient adherence to DOTS in urban Kathmandu, Nepal.
    Bam TS; Gunneberg C; Chamroonsawasdi K; Bam DS; Aalberg O; Kasland O; Shiyalap K; Srisorrachatr S
    Int J Tuberc Lung Dis; 2006 Mar; 10(3):270-6. PubMed ID: 16562706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Remote results of short-term treatment of pulmonary tuberculosis with a combination of isoniazid, rifampin and ethambutol].
    Sosnowski W; Krawczyk Z; Górnicka-Wilczyńska M; Pilarska-Machowicz A; Pruszyńska S; Pawlik J; Wardowa A; Woźniak B; Tomaszkiewicz L
    Pneumonol Pol; 1980 Nov; 48(11):663-8. PubMed ID: 7255206
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antitubercular chemotherapy].
    Jouveshomme S; Dautzenberg B
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S88-104. PubMed ID: 9496594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with compliance among tuberculosis patients in Thailand.
    Lertmaharit S; Kamol-Ratankul P; Sawert H; Jittimanee S; Wangmanee S
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S149-56. PubMed ID: 16623020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Profile of the patients lost to treatment in the National Anti-Tuberculosis Program in Madagascar].
    Rakotomanana F; Rabarijaona LP; Ratsitorahina M; Cauchoix B; Razafinimanana J; Ratsirahonana A; Boisier P; Aurégan G
    Sante; 1999; 9(4):225-9. PubMed ID: 10623869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tuberculosis therapy in canton Zurich 1991-1993: what are the causes for recurrence and therapy failure?].
    Rose N; Shang H; Pfyffer GE; Brändli O
    Schweiz Med Wochenschr; 1996 Nov; 126(48):2059-67. PubMed ID: 8992625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chemotherapy of tuberculosis--compliance, side effects and incidence of recurrence].
    Brändli O; Häcki MA; Scheel A; Stiefel M
    Schweiz Med Wochenschr; 1983 Jan; 113(3):92-6. PubMed ID: 6828844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Short-term chemotherapy for juvenile tuberculosis].
    Tamura N
    Kekkaku; 1983 Dec; 58(12):625-30. PubMed ID: 6672419
    [No Abstract]   [Full Text] [Related]  

  • 33. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of advanced and complicated variants of osteoarticular tuberculosis with rifampin and ethambutol].
    Suleĭmanov I; Prosvirova LA; Umarov B; Beliakova NK
    Probl Tuberk; 1981 Dec; (12):49-52. PubMed ID: 7335634
    [No Abstract]   [Full Text] [Related]  

  • 35. [The usefulness of the desensitization to rifampin in the treatment of mycobacterial disease in patients with AIDS].
    Arrizabalaga J; Casas A; Camino X; Iribarren JA; Rodríguez Arrondo F; Von Wichmann MA
    Med Clin (Barc); 1998 Jun; 111(3):103-4. PubMed ID: 9706604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acute renal insufficiency and rifampicin: experience in 2 cases with clinical and histological observations].
    Tarchini R; Mioli V; Ragaiolo M; Figus S; Lombardo V
    G Clin Med; 1981 Jul; 62(7):485-94. PubMed ID: 7308632
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors determining compliance with tuberculosis treatment in an urban environment, Tamatave, Madagascar.
    Comolet TM; Rakotomalala R; Rajaonarioa H
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):891-7. PubMed ID: 9848609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs for tuberculosis.
    Med Lett Drugs Ther; 1995 Aug; 37(954):67-70. PubMed ID: 7616907
    [No Abstract]   [Full Text] [Related]  

  • 40. Rifampicin/pyrazinamide therapy should not be used for latent tuberculosis infection.
    Garca-Doval I
    J Am Acad Dermatol; 2004 May; 50(5):801; author reply 801-2. PubMed ID: 15097974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.